September 22-23, 2016
NICHD, Office of Research on Women's Health (ORWH)
Bethesda North Marriott and Conference Center
5701 Marinelli Road, North Bethesda, Maryland
ZIKV is a growing, global epidemic. ZIKV has been associated with numerous birth and developmental defects, such as microcephaly, and other pregnancy and birth-related problems, including miscarriages, stillbirths, and other in utero complications. Because of these health issues, it is imperative that the scientific community understand the effects of ZIKV on pregnancy and pregnancy outcomes. The purpose of this workshop is to identify optimal approaches for treating and caring for the generation of children exposed to ZIKV in the womb.
The objectives of this workshop are to:
- Develop research strategies on how to appropriately assess, evaluate, and monitor the neonate/infant/child affected by ZIKV in utero based on available clinical guidelines
- Identify research strategies to improve evaluation for new/emerging complications of in utero ZIKV exposure and infection and to understand the prospective impact of these complications on the developing child
- Use available information from other vertically transmitted pathogens to provide recommendations for assessment, evaluation, and management
- Outline the research needs for treatment and rehabilitation approaches that optimize cognitive and physical function for Zika-affected children; and
- Evaluate and expand on treatment options currently offered, such as intensive physical therapy and immersion therapies, role of parents and caregivers in treatments, including the evidence base for these therapies and current research gaps.
If you require a sign language interpreters and/or reasonable accommodations to participate, please contact Christine Rogers (301-402-2205 or firstname.lastname@example.org) or the Federal TTY Relay Number (1-800-877-8339). Please make your requests at least 5 days in advance of the event.
For logistical questions:
Carly Sullivan, Palladian Partners, Inc.
For content or meeting questions:
Bill Kapogiannis, Maternal and Pediatric Infectious Disease Branch, Division of Extramural Research, NICHD